NetraMark Holdings (AIAI.C): Failed FDA trials cost billions, NetraAI may prevent them
NetraMark Holdings (CSE: AIAI) uses its NetraAI engine to identify hidden patient subpopulations in clinical-trial data, aiming to rescue drugs that fail because they work… Read More »NetraMark Holdings (AIAI.C): Failed FDA trials cost billions, NetraAI may prevent them
